|
T.LABS
|
I don't recall this....retail shareholders represent minimum 350 million...
|
|
T.LABS
|
https://www.precedenceresearch.com/cannabis-pharmaceuticals-market/amp
|
|
T.LABS
|
In November 2023, MediPharm Labs' top-performing product was the 'CBN...
|
|
C.ERTH
|
https://youtu.be/YdDPVTU2Vbk?si=mP5gKh5YAQgzhY77 ...
|
|
C.ERTH
|
https://youtu.be/_nTyiCPFDiE?si=7Wwq7dBS_mUwXC9x
|
|
T.LABS
|
Fair value 17c cdn...just on current assets..courtesy of MR Deadlocks amazing...
|
|
T.LABS
|
M&A.."all equity" at 0.065 cdn..398 million shares out..don'...
|
|
C.ERTH
|
Management commentary suggests the finalization/ of this grant expected this...
|
|
T.LABS
|
https://labsinvestor.com/
|
|
T.LABS
|
NDA, ANDA, 505b2, AVISA/product, approval, partnership names, commercial date...
|
|
T.LABS
|
Yeah it's a clear error. CFO, CEO, financials are correct....under 2.5m...
|
|
C.ERTH
|
I'm curious about the cap and trade aspect....potential to sell credits...
|
|
T.LABS
|
https://medium.com/@microcap023/unveiling-the-comprehensive-analysis-of...
|
|
T.LABS
|
Yeah, it's frustrating..look at Danny deadlocks 40pg report..the business...
|
|
T.LABS
|
Yes, generics are cheaper..I continue repeating..Epidiolex, pure cannabidol...
|
|
T.LABS
|
11:28:50 H 0.07 2,000 1...
|
|
T.LABS
|
Yes, and considering the news... HEXO recievable..Aussie OTC..Brazilian...
|
|
T.LABS
|
Agree!...feels like sentiment is shifting in our favour...let's see this...
|
|
T.LABS
|
I agree..Verdemed doesn't manufacture API...Labs has the credentials for...
|
|
T.LABS
|
The industry generated sales of R$39.8 million in the third quarter, a 120...
|